Gacyclidine

Drug Profile

Gacyclidine

Alternative Names: GK 11

Latest Information Update: 30 Aug 2004

Price : $50

At a glance

  • Originator Ipsen
  • Class Cyclohexanes; Neuroprotectants; Piperidines; Small molecules; Thiophenes
  • Mechanism of Action NMDA receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Brain injuries; Postoperative pain; Spinal cord injuries

Most Recent Events

  • 30 Aug 2004 Discontinued - Preclinical for Postoperative pain in France (unspecified route)
  • 30 Aug 2004 Discontinued - Phase-II for Spinal cord injuries (unspecified route)
  • 30 Aug 2004 Discontinued - Phase-II for Brain injuries (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top